What are the recommended maintenance infusion rates for common continuous‑infusion drugs in a 100‑kg adult patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maintenance Infusion Protocols for a 100 kg Patient

The question lacks specificity regarding which drug, but I'll provide the most commonly used continuous infusion protocols for a 100 kg adult patient based on the strongest guideline evidence.

Hypertensive Emergency Medications

For blood pressure control in hypertensive emergencies, the following weight-based maintenance infusions apply to a 100 kg patient 1, 2:

First-Line Agents

  • Nicardipine: Start 5 mg/h, titrate by 2.5 mg/h every 5 minutes to maximum 15 mg/h (not weight-based)

  • Clevidipine: Start 1-2 mg/h, double every 90 seconds until BP approaches target, then increase by less than double every 5-10 minutes; maximum 32 mg/h (not weight-based)

  • Esmolol:

    • Loading: 50-100 mg over 1 minute (500-1000 mcg/kg/min)
    • Maintenance: Start at 5 mg/min (50 mcg/kg/min), increase in 5 mg/min increments to maximum 20 mg/min (200 mcg/kg/min)
  • Labetalol:

    • Bolus option: 30-100 mg slow IV every 10 minutes (0.3-1.0 mg/kg, max 20 mg)
    • Infusion: Start 40-100 mg/h (0.4-1.0 mg/kg/h), titrate up to 300 mg/h (3 mg/kg/h)

Alternative Agents

  • Sodium Nitroprusside: Start 30-50 mcg/min (0.3-0.5 mcg/kg/min), increase by 50 mcg/min increments to maximum 1000 mcg/min (10 mcg/kg/min). Critical caveat: Requires arterial line monitoring; cyanide toxicity risk with rates ≥400 mcg/min or duration >30 minutes 2

  • Nitroglycerin: Start 5 mcg/min, increase by 5 mcg/min every 3-5 minutes to maximum 20 mcg/min (not weight-based)

  • Fenoldopam: Start 10-30 mcg/min (0.1-0.3 mcg/kg/min), increase by 5-10 mcg/min every 15 minutes to maximum 160 mcg/min (1.6 mcg/kg/min)

Sedation in ICU

For continuous sedation in mechanically ventilated patients 3, 4:

  • Propofol:

    • Loading: 25 mg over 5 minutes (0.25 mg/kg) if hemodynamically stable
    • Maintenance: Start 6 mg/kg/h (600 mg/h for 100 kg), titrate to 5-50 mcg/kg/min (30-300 mg/h)
  • Midazolam:

    • Loading: 5 mg over several minutes (0.05 mg/kg)
    • Maintenance: 2-10 mg/h (0.02-0.1 mg/kg/h)
  • Lorazepam:

    • Loading: 2-4 mg (0.02-0.04 mg/kg, max 2 mg)
    • Maintenance: 1-10 mg/h (0.01-0.1 mg/kg/h, max 10 mg/h)
  • Dexmedetomidine:

    • Loading: 100 mcg over 10 minutes (1 mcg/kg) - avoid in hemodynamically unstable patients
    • Maintenance: 20-70 mcg/h (0.2-0.7 mcg/kg/h), may increase to 150 mcg/h (1.5 mcg/kg/h)

Vasopressor/Inotrope Support

For shock states 5:

  • Norepinephrine: 2-20 mcg/kg/min (200-2000 mcg/min for 100 kg)

  • Epinephrine: 0.1-1.0 mcg/kg/min (10-100 mcg/min for 100 kg), up to 5 mcg/kg/min in exceptional circumstances

  • Dopamine: 2-20 mcg/kg/min (200-2000 mcg/min for 100 kg)

  • Dobutamine: 2-20 mcg/kg/min (200-2000 mcg/min for 100 kg)

Critical Considerations

Common pitfalls to avoid:

  1. Esmolol and labetalol are contraindicated in bradycardia, heart block, decompensated heart failure, and reactive airway disease 1, 2, 6

  2. Nitroprusside requires cyanide toxicity monitoring with prolonged use or high doses; consider co-administration of thiosulfate 2

  3. Propofol carries risk of propofol-related infusion syndrome at high doses/prolonged duration; monitor triglycerides 3

  4. Lorazepam can cause propylene glycol toxicity with prolonged infusions, leading to metabolic acidosis and nephrotoxicity 3

  5. All vasopressors require central line access when possible; extravasation causes severe tissue injury. Have phentolamine 10 mg in 10 mL saline ready for intradermal injection at extravasation sites 5, 7

Titration principles:

  • Hypertensive emergency agents should reduce BP by no more than 25% in first hour, then to 160/100 mmHg over 2-6 hours 2
  • Sedation requires frequent reassessment (every 5-10 minutes initially) using validated scales (Ramsay, RASS) 3, 4
  • Vasopressors should be titrated to MAP ≥65 mmHg or clinical endpoints of perfusion

Related Questions

What are the key principles of pre‑operative assessment and the recommended approach to common post‑operative complications according to Canadian guidelines?
How should a 23-year-old male presenting with dysuria and urethral discharge be evaluated and treated?
In a 15‑year‑old male with persistent left lower‑quadrant abdominal tenderness and bruising, right‑sided back pain radiating to the ribs, and new left great‑toe stabbing pain with tingling after a recent appendectomy, what imaging studies and medical management are indicated?
How should a 24‑week pregnant woman with an 18‑lb weight gain be evaluated and managed?
In a 23‑year‑old woman with dysuria, burning and tearing sensation during and after intercourse, should she be referred to a gynecologist first or a urologist?
In a patient 10 months post‑fistulotomy with chronic rectal neuropathic pain, numbness, burning, and pain‑induced urinary urgency/frequency/dysuria, is the bladder involvement an overlap of the same neuropathic pelvic‑floor dysfunction or a separate issue?
How should dementia that develops three years after endovascular coiling of an anterior communicating artery aneurysm in an older adult be evaluated and managed?
How should hepatic hydrothorax be managed?
How should acute wrist swelling be evaluated and managed?
How should total parenteral nutrition be started in a chronically malnourished patient with abdominal tuberculosis (Koch's abdomen)?
What are the recommended management steps for acute upper gastrointestinal bleeding, including resuscitation, blood transfusion targets, anticoagulant reversal, intravenous proton‑pump inhibitor therapy, endoscopic treatment, and post‑procedure care?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.